{"transactions":[{"id":730012,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2026-06-22T20:30:49.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027."}],"balance_after":51700,"derivative":{"exercise_price":2.55,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001650664-26-000071","document":"wk-form4_1782160247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066426000071/wk-form4_1782160247.xml","form_type":"4"}},{"id":768417,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T20:33:24.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":1660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2027."}],"balance_after":29355,"source":{"system":"sec-edgar","filing":"0001145197-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519726000124/form4.xml","form_type":"4"}},{"id":1105930,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-18T22:24:10.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":89139,"price":2.16,"value":192540.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on June 16, 2025, which vest in full upon the earlier of one year from the date of grant or the date of the 2026 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders."}],"balance_after":199907,"source":{"system":"sec-edgar","filing":"0001823239-25-000081","document":"wk-form4_1750285443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000182323925000081/wk-form4_1750285443.xml","form_type":"4"}},{"id":1115977,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2025-06-10T20:19:40.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026."}],"balance_after":37500,"derivative":{"exercise_price":1.91,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001650664-25-000103","document":"wk-form4_1749586773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066425000103/wk-form4_1749586773.xml","form_type":"4"}},{"id":1133791,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-27T20:06:48.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2026."}],"balance_after":27695,"source":{"system":"sec-edgar","filing":"0001127602-25-015648","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760225015648/form4.xml","form_type":"4"}},{"id":1149587,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-14T20:15:23.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":5235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which is fully vested, vested over a three-year period, with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":28.87,"exercise_date":"2017-04-30","expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":5235},"source":{"system":"sec-edgar","filing":"0001127602-25-014271","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760225014271/form4.xml","form_type":"4"}},{"id":1149586,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-14T20:15:23.000Z","date":"2025-05-13","kind":"sale","planned":false,"acquired":false,"shares":5235,"price":317.54,"value":1662321.9,"ownership":{"direct":true},"balance_after":26917,"source":{"system":"sec-edgar","filing":"0001127602-25-014271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760225014271/form4.xml","form_type":"4"}},{"id":1149585,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-14T20:15:23.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":5235,"price":28.87,"value":151134.45,"ownership":{"direct":true},"balance_after":32152,"source":{"system":"sec-edgar","filing":"0001127602-25-014271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760225014271/form4.xml","form_type":"4"}},{"id":1408987,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-12T20:07:52.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":false,"shares":7628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant."}],"balance_after":0,"derivative":{"exercise_price":29.87,"expiration_date":"2025-07-27","underlying":"Common Stock","underlying_shares":7628},"source":{"system":"sec-edgar","filing":"0001127602-24-023843","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224023843/form4.xml","form_type":"4"}},{"id":1408986,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-12T20:07:52.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":7628,"price":225.26,"value":1718283.28,"ownership":{"direct":true},"balance_after":26917,"source":{"system":"sec-edgar","filing":"0001127602-24-023843","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224023843/form4.xml","form_type":"4"}},{"id":1408985,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-12T20:07:52.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":true,"shares":7628,"price":29.87,"value":227848.36,"ownership":{"direct":true},"balance_after":34545,"source":{"system":"sec-edgar","filing":"0001127602-24-023843","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224023843/form4.xml","form_type":"4"}},{"id":1494756,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T21:14:39.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024  and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000071","document":"wk-form4_1717449268.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066424000071/wk-form4_1717449268.xml","form_type":"4"}},{"id":1501503,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-24T21:58:04.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":20645,"price":10.78,"value":222553.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on May 23, 2024, which vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders."}],"balance_after":110768,"source":{"system":"sec-edgar","filing":"0001823239-24-000075","document":"wk-form4_1716587874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000182323924000075/wk-form4_1716587874.xml","form_type":"4"}},{"id":1504014,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-23T21:08:55.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). These RSUs vest in full on April 30, 2025 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":26917,"source":{"system":"sec-edgar","filing":"0001127602-24-016459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224016459/form4.xml","form_type":"4"}},{"id":1516960,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T20:17:23.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":45000,"price":5.6415,"value":253867.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $5.43 to $5.83. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67700,"source":{"system":"sec-edgar","filing":"0001650664-24-000039","document":"wk-form4_1715717825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000165066424000039/wk-form4_1715717825.xml","form_type":"4"}},{"id":1767552,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T15:31:23.000Z","date":"2023-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105207,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share (\"Common Stock\") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share (\"Common Stock\") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by her in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-019737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000089924323019737/doc4.xml","form_type":"4"}},{"id":1767551,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T15:31:23.000Z","date":"2023-10-02","kind":"exercise","planned":false,"acquired":false,"shares":74030,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the \"Merger Agreement\"), by and among Bruker Corporation (\"Bruker\"), Bird Mergersub Corporation (\"Merger Sub\") and Phenomex Inc. (the \"Company\"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the \"Merger\"), and each restricted stock unit (\"RSU\") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the \"Merger Agreement\"), by and among Bruker Corporation (\"Bruker\"), Bird Mergersub Corporation (\"Merger Sub\") and Phenomex Inc. (the \"Company\"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the \"Merger\"), and each restricted stock unit (\"RSU\") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger, the Reporting Person disposed of each RSU held by her in exchange for the Merger Consideration."}],"balance_after":105207,"source":{"system":"sec-edgar","filing":"0000899243-23-019737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000089924323019737/doc4.xml","form_type":"4"}},{"id":1826616,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-19T20:50:54.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders."}],"balance_after":90123,"source":{"system":"sec-edgar","filing":"0001823239-23-000065","document":"wf-form4_168979983995803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000182323923000065/wf-form4_168979983995803.xml","form_type":"4"}},{"id":1866071,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:47.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and will vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009232","document":"form4-06052023_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000141588923009232/form4-06052023_040609.xml","form_type":"4"}},{"id":1872045,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T16:25:45.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 75,642 RSUs."}],"balance_after":179237,"source":{"system":"sec-edgar","filing":"0001104659-23-067060","document":"tm2317396d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000110465923067060/tm2317396d6_4.xml","form_type":"4"}},{"id":1880002,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-24T20:08:40.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  These RSUs vest in full on April 30, 2024 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":25537,"source":{"system":"sec-edgar","filing":"0001127602-23-016713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760223016713/form4.xml","form_type":"4"}},{"id":2199079,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-01T18:48:58.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":32258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options will fully vest on May 26, 2023."}],"balance_after":32258,"derivative":{"exercise_price":4.6,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":32258},"source":{"system":"sec-edgar","filing":"0001567619-22-014734","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922014734/doc1.xml","form_type":"4"}},{"id":2199078,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-01T18:48:58.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":19565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 29,237 RSUs."}],"balance_after":109237,"source":{"system":"sec-edgar","filing":"0001567619-22-014734","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922014734/doc1.xml","form_type":"4"}},{"id":2233635,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:30:23.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023."}],"balance_after":25000,"derivative":{"exercise_price":12.31,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-22-006490","document":"form4-06132022_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000141588922006490/form4-06132022_040611.xml","form_type":"4"}},{"id":2255490,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-26T20:08:30.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":1009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":24694,"source":{"system":"sec-edgar","filing":"0001127602-22-015763","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760222015763/form4.xml","form_type":"4"}},{"id":2337631,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-11T18:35:24.000Z","date":"2022-03-10","kind":"purchase","acquired":true,"shares":80000,"price":6.28,"value":502400.0,"ownership":{"direct":true},"balance_after":89672,"source":{"system":"sec-edgar","filing":"0001567619-22-006797","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922006797/doc1.xml","form_type":"4"}},{"id":2337630,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T18:27:47.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":16507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 36 equal monthly installments until fully vested on December 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to a scrivener's error, the reporting person's previous form 4 filing indicated a grant of 9,672 options, which is the total amount of restricted stock units that were awarded to the reporting person and that were appropriately reflected in table I of the reporting person's previous form 4. In fact, the option grant to the reporting person was 16,507 options. This amount was also appropriately reflected in the Current Report on Form 8-K filed by Berkely Lights Inc. (the \"Company\") regarding the reporting person's appointment as a director of the Company."}],"balance_after":16507,"derivative":{"exercise_price":18.61,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":16507},"source":{"system":"sec-edgar","filing":"0001567619-22-006796","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761922006796/doc1.xml","form_type":"4/A","original_submission_date":"2021-12-20"}},{"id":2463914,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-20T17:40:00.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":9672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in 36 equal monthly installments until fully vested on December 15, 2024."}],"balance_after":9672,"derivative":{"exercise_price":18.61,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":9672},"source":{"system":"sec-edgar","filing":"0001567619-21-022346","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761921022346/doc1.xml","form_type":"4"}},{"id":2463913,"issuer":{"id":109250,"kind":"organization","name":"Bruker Cellular Analysis, Inc.","symbol":"CELL"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T17:40:00.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":9672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which will vest with respect to one-third of the shares on December 15, 2022, and will vest with respect to the remainder of the shares in equal quarterly installments thereafter until fully vested on December 15, 2024. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting."}],"balance_after":9672,"source":{"system":"sec-edgar","filing":"0001567619-21-022346","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689657/000156761921022346/doc1.xml","form_type":"4"}},{"id":2497041,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-23T21:16:13.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":4271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on November 19, 2021, which vest in full one year from the date of the grant."}],"balance_after":66123,"source":{"system":"sec-edgar","filing":"0000899243-21-045774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000089924321045774/doc4.xml","form_type":"4"}},{"id":2678743,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-07T20:09:56.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2021 and is scheduled to vest in full on June 3, 2022."}],"balance_after":11538,"derivative":{"exercise_price":33.36,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001179110-21-006450","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000117911021006450/edgar.xml","form_type":"4"}},{"id":2691656,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-28T20:07:03.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). RSUs vest in full on April 30, 2022 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":23685,"source":{"system":"sec-edgar","filing":"0001127602-21-018307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018307/form4.xml","form_type":"4"}},{"id":2805171,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-05T21:13:37.000Z","date":"2021-03-03","kind":"purchase","acquired":true,"shares":5800,"price":45.512,"value":263969.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $45.48 to $45.59. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22700,"source":{"system":"sec-edgar","filing":"0001179110-21-002936","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000117911021002936/edgar.xml","form_type":"4"}},{"id":2965674,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-11-26T00:52:17.000Z","date":"2020-11-24","kind":"purchase","acquired":true,"shares":50000,"price":27,"value":1350000.0,"ownership":{"direct":true},"balance_after":61852,"source":{"system":"sec-edgar","filing":"0000899243-20-032216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000089924320032216/doc4.xml","form_type":"4"}},{"id":2969425,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-11-23T22:32:04.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":11852,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11852,"source":{"system":"sec-edgar","filing":"0000899243-20-031946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000089924320031946/doc4.xml","form_type":"4"}},{"id":3111409,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T20:19:20.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2020 and is scheduled to vest in full on June 10, 2021."}],"balance_after":11538,"derivative":{"exercise_price":27.49,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001179110-20-007277","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000117911020007277/edgar.xml","form_type":"4"}},{"id":3129296,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-01T20:53:47.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":1029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  RSUs vest in full on April 30, 2021 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":22877,"source":{"system":"sec-edgar","filing":"0001127602-20-018245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220018245/form4.xml","form_type":"4"}},{"id":3252772,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-24T17:57:23.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on February 20, 2021, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":19.96,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-012151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919120012151/doc4.xml","form_type":"4"}},{"id":3252771,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-24T17:57:23.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on February 20, 2021, subject to continued service with RDUS through such date."}],"balance_after":18300,"source":{"system":"sec-edgar","filing":"0001209191-20-012151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919120012151/doc4.xml","form_type":"4"}},{"id":3488993,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:30:21.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2019 and is scheduled to vest in full on June 12, 2020."}],"balance_after":11538,"derivative":{"exercise_price":21.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001179110-19-007682","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000117911019007682/edgar.xml","form_type":"4"}},{"id":3504980,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-06-03T21:41:49.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":1726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  RSUs vest in full on April 30, 2020 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":21848,"source":{"system":"sec-edgar","filing":"0001127602-19-020537","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219020537/form4.xml","form_type":"4"}},{"id":3605728,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-07T21:02:02.000Z","date":"2019-03-05","kind":"purchase","acquired":true,"shares":10200,"price":23.94,"value":244188.0,"ownership":{"direct":true},"balance_after":16900,"source":{"system":"sec-edgar","filing":"0001179110-19-003510","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000117911019003510/edgar.xml","form_type":"4"}},{"id":3608256,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-06T16:29:52.000Z","date":"2019-03-05","kind":"purchase","acquired":true,"shares":12800,"price":19.2336,"value":246190.08,"ownership":{"direct":true},"balance_after":12800,"source":{"system":"sec-edgar","filing":"0001209191-19-017351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119017351/doc4.xml","form_type":"4"}},{"id":3686661,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-25T16:06:07.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in substantially equal installments on each of the first four anniversaries of January 24, 2019."}],"balance_after":30000,"derivative":{"exercise_price":17.1,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-005314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119005314/doc4.xml","form_type":"4"}},{"id":3923433,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T20:27:50.000Z","date":"2018-05-17","kind":"purchase","acquired":true,"shares":6700,"price":37.2806,"value":249780.02,"ownership":{"direct":true},"balance_after":6700,"source":{"system":"sec-edgar","filing":"0001179110-18-007231","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000117911018007231/edgar.xml","form_type":"4"}},{"id":3926062,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-18T21:51:25.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":2185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 2,185 restricted stock units vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,402 restricted stock units granted on July 27, 2015, which vest on July 27, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":20122,"source":{"system":"sec-edgar","filing":"0001127602-18-018180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218018180/form4.xml","form_type":"4"}},{"id":4051141,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T21:08:03.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":23076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2018 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on February 14, 2019 through February 14, 2021."}],"balance_after":23076,"derivative":{"exercise_price":34.59,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":23076},"source":{"system":"sec-edgar","filing":"0001179110-18-002258","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648715/000117911018002258/edgar.xml","form_type":"4"}},{"id":4313842,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-18T22:32:34.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":3587,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3587,"derivative":{"exercise_price":40.6,"exercise_date":"2018-04-30","expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":3587},"source":{"system":"sec-edgar","filing":"0001127602-17-018712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217018712/form4.xml","form_type":"4"}},{"id":4313841,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-18T22:32:34.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":2709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 2,709 restricted stock units vest on April 30, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,804 restricted stock units granted on July 27, 2015, which vest 50% of the total units on July 27, 2017 and 50% of the total units on July 27, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":17937,"source":{"system":"sec-edgar","filing":"0001127602-17-018712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217018712/form4.xml","form_type":"4"}},{"id":4323016,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":36220,"kind":"person","name":"Hopfield Jessica","position":1,"cik":"0001648715","reported_name":"Hopfield Jessica","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-12T12:33:14.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":2580,"price":38.6754,"value":99782.532,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price of the shares purchased.  The shares were purchased at varying prices in the range of $38.6399 to $38.6792.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,804 restricted stock units granted on July 27, 2015, which vest 50% of the total units on July 27, 2017 and 50% of the total units on July 27, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":15228,"source":{"system":"sec-edgar","filing":"0001127602-17-017836","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217017836/form4.xml","form_type":"4"}}]}